Ranjit S Bindra (Ranjit Bindra)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 29

Top Topics

Metastatic Colorectal Cancer

Top Venues

Molecular cancer therapeutics

Science advances

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Katelyn J Noronha, Karlie N Lucas, Sateja Paradkar, Joseph Edmonds, Sam Friedman, Matthew A Murray, Samantha Liu, Dipti P Sajed, Chana Sachs, Joshua Spurrier, Mitch Raponi, Jiayu Liang, Hao Zeng, Ranjini K Sundaram, Brian M Shuch, Juan C Vasquez, Ranjit S Bindra
NAPRT silencing in FH-deficient renal cell carcinoma confers therapeutic vulnerabilities via NAD+ depletion. Molecular cancer research : MCR (2024)
Matthew A Murray, Katelyn J Noronha, Yazhe Wang, Anna P Friedman, Sateja Paradkar, Hee Won Suh, Ranjini K Sundaram, Charles Brenner, W Mark Saltzman, Ranjit S Bindra
Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors. Molecular cancer therapeutics 23 (8) (2024)
Matthew A Murray, Katelyn J Noronha, Yazhe Wang, Anna P Friedman, Sateja Paradkar, Hee Won Suh, Ranjini K Sundaram, Charles Brenner, W Mark Saltzman, Ranjit S Bindra
Exploiting Metabolic Defects in Glioma with Nanoparticle Encapsulated NAMPT Inhibitors. Molecular cancer therapeutics (2024)
Matthew A Murray, Katelyn J Noronha, Yazhe Wang, Anna P Friedman, Sateja Paradkar, Hee Won Suh, Ranjini K Sundaram, Charles Brenner, W Mark Saltzman, Ranjit S Bindra
Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors. Molecular cancer therapeutics 23 (8) (2024)
Matthew A Murray, Katelyn J Noronha, Yazhe Wang, Anna P Friedman, Sateja Paradkar, Hee Won Suh, Ranjini K Sundaram, Charles Brenner, W Mark Saltzman, Ranjit S Bindra
Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors. Molecular cancer therapeutics 23 (8) (2024)
Matthew A Murray, Katelyn J Noronha, Yazhe Wang, Anna P Friedman, Sateja Paradkar, Hee Won Suh, Ranjini K Sundaram, Charles Brenner, W Mark Saltzman, Ranjit S Bindra
Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors. Molecular cancer therapeutics 23 (8) (2024)
Yazhe Wang, Shipra Malik, Hee Won Suh, Yong Xiao, Yanxiang Deng, Rong Fan, Anita Huttner, Ranjit S Bindra, Vijender Singh, W Mark Saltzman, Raman Bahal
Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy. Science advances 9 (6) (2023)
Kristina A Fanucci, Mary Jo Pilat, Derek Shyr, Yu Shyr, Scott A Boerner, Jing Li, Diane E Durecki, Jan Drappatz, Vinay K Puduvalli, Frank Scott Lieberman, Javier Gonzalez, Pierre Giglio, Susan Percy Ivy, Ranjit S Bindra, Antonio Omuro, Patricia M LoRusso
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2 -mutant Glioma. Cancer research communications 3 (2) (2023)
Kristina A Fanucci, Mary Jo Pilat, Derek Shyr, Yu Shyr, Scott A Boerner, Jing Li, Diane E Durecki, Jan Drappatz, Vinay K Puduvalli, Frank Scott Lieberman, Javier Gonzalez, Pierre Giglio, Susan Percy Ivy, Ranjit S Bindra, Antonio Omuro, Patricia M LoRusso
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2 -mutant Glioma. Cancer research communications 3 (2) (2023)
Yazhe Wang, Shipra Malik, Hee Won Suh, Yong Xiao, Yanxiang Deng, Rong Fan, Anita Huttner, Ranjit S Bindra, Vijender Singh, W Mark Saltzman, Raman Bahal
Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy. Science advances 9 (6) (2023)
Yazhe Wang, Shipra Malik, Hee Won Suh, Yong Xiao, Yanxiang Deng, Rong Fan, Anita Huttner, Ranjit S Bindra, Vijender Singh, W Mark Saltzman, Raman Bahal
Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy. Science advances 9 (6) (2023)
Yazhe Wang, Shipra Malik, Hee Won Suh, Yong Xiao, Yanxiang Deng, Rong Fan, Anita Huttner, Ranjit S Bindra, Vijender Singh, W Mark Saltzman, Raman Bahal
Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy. Science advances 9 (6) (2023)
Michael Cecchini, Janie Y Zhang, Wei Wei, Jeffrey S Sklar, Jill Lacy, Minghao Zhong, Yong Kong, Hongyu Zhao, Jassim DiPalermo, Lesley Devine, Stacey M Stein, Jeremy Kortmansky, Kimberly L Johung, Ranjit S Bindra, Patricia M LoRusso, Kurt A Schalper
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer. Cancer research communications 3 (6) (2023)
Yazhe Wang, Shipra Malik, Hee Won Suh, Yong Xiao, Yanxiang Deng, Rong Fan, Anita Huttner, Ranjit S Bindra, Vijender Singh, W Mark Saltzman, Raman Bahal
Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy. Science advances 9 (6) (2023)
Michael Cecchini, Janie Y Zhang, Wei Wei, Jeffrey S Sklar, Jill Lacy, Minghao Zhong, Yong Kong, Hongyu Zhao, Jassim DiPalermo, Lesley Devine, Stacey M Stein, Jeremy Kortmansky, Kimberly L Johung, Ranjit S Bindra, Patricia M LoRusso, Kurt A Schalper
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer. Cancer research communications 3 (6) (2023)
Michael Cecchini, Janie Y Zhang, Wei Wei, Jeffrey S Sklar, Jill Lacy, Minghao Zhong, Yong Kong, Hongyu Zhao, Jassim DiPalermo, Lesley Devine, Stacey M Stein, Jeremy Kortmansky, Kimberly L Johung, Ranjit S Bindra, Patricia M LoRusso, Kurt A Schalper
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer. Cancer research communications 3 (6) (2023)
Minsoo Khang, Ju-Hyun Lee, Teresa Lee, Hee Won Suh, Supum Lee, Alessandra Cavaliere, Amy Rushing, Luiz Henrique Medeiros Geraldo, Erika Belitzky, Samantha M Rossano, Henk M De Feyter, Kwangsoo Shin, Anita Huttner, Martine F Roussel, Jean-Léon Thomas, Richard E Carson, Bernadette Marquez-Nostra, Ranjit S Bindra, W Mark Saltzman
Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma. Science translational medicine 15 (720) (2023)
Julie J Miller, L Nicolas Gonzalez Castro, Samuel McBrayer, Michael Weller, Timothy Cloughesy, Jana Portnow, Ovidiu Andronesi, Jill S Barnholtz-Sloan, Brigitta G Baumert, Mitchell S Berger, Wenya Linda Bi, Ranjit S Bindra, Daniel P Cahill, Susan M Chang, Joseph F Costello, Craig M Horbinski, Raymond Y Huang, Robert B Jenkins, Keith L Ligon, Ingo K Mellinghoff, L Burt Nabors, Michael Platten, David A Reardon, Diana D Shi, David Schiff, Wolfgang Wick, Hai Yan, Andreas von Deimling, Martin van den Bent, William G Kaelin, Patrick Y Wen
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. Neuro-oncology (2022)
Kingson Lin, Susan E Gueble, Ranjini K Sundaram, Eric D Huseman, Ranjit S Bindra, Seth B Herzon
Mechanism-based design of agents that selectively target drug-resistant glioma. Science (New York, N.Y.) 377 (6605) (2022)
Ukhyun Jo, Yasuhisa Murai, Keli K Agama, Yilun Sun, Liton Kumar Saha, Xi Yang, Yasuhiro Arakawa, Sophia Gayle, Kelli Jones, Vishwas Paralkar, Ranjini K Sundaram, Jinny Van Doorn, Juan C Vasquez, Ranjit S Bindra, Woo Suk Choi, Yves Pommier
TOP1-DNA Trapping by Exatecan and Combination Therapy with ATR Inhibitor. Molecular cancer therapeutics 21 (7) (2022)
Amrita Sule, Jinny Van Doorn, Ranjini K Sundaram, Sachita Ganesa, Juan C Vasquez, Ranjit S Bindra
Targeting IDH1/2 mutant cancers with combinations of ATR and PARP inhibitors. NAR cancer 3 (2) (2021)
Sophia Gayle, Robert Aiello, Nalin Leelatian, Jason M Beckta, Jane Bechtold, Patricia Bourassa, Johanna Csengery, Robert J Maguire, Dan Marshall, Ranjini K Sundaram, Jinny Van Doorn, Kelli Jones, Hunter Moore, Lori Lopresti-Morrow, Timothy Paradis, Laurie Tylaska, Qing Zhang, Hannah Visca, Yana K Reshetnyak, Oleg A Andreev, Donald M Engelman, Peter M Glazer, Ranjit S Bindra, Vishwas M Paralkar
Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity. NAR cancer 3 (2) (2021)
Yongheng Wang, Yuhang Jiang, Dengshuai Wei, Priya Singh, Yingjie Yu, Teresa Lee, Lingpu Zhang, Hanna K Mandl, Alexandra S Piotrowski-Daspit, Xinyuan Chen, Fan Li, Xing Li, Yiyu Cheng, Alexander Josowitz, Fan Yang, Yao Zhao, Fu-Yi Wang, Zhenwen Zhao, Anita Huttner, Ranjit S Bindra, Haihua Xiao, W Mark Saltzman
Nanoparticle-mediated convection-enhanced delivery of a DNA intercalator to gliomas circumvents temozolomide resistance. Nature biomedical engineering 5 (9) (2021)
Sophia Gayle, Robert Aiello, Nalin Leelatian, Jason M Beckta, Jane Bechtold, Patricia Bourassa, Johanna Csengery, Robert J Maguire, Dan Marshall, Ranjini K Sundaram, Jinny Van Doorn, Kelli Jones, Hunter Moore, Lori Lopresti-Morrow, Timothy Paradis, Laurie Tylaska, Qing Zhang, Hannah Visca, Yana K Reshetnyak, Oleg A Andreev, Donald M Engelman, Peter M Glazer, Ranjit S Bindra, Vishwas M Paralkar
Correction to 'Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity'. NAR cancer 3 (4) (2021)
Alessandro Cicconi, Rekha Rai, Xuexue Xiong, Cayla Broton, Amer Al-Hiyasat, Chunyi Hu, Siying Dong, Wenqi Sun, Jennifer Garbarino, Ranjit S Bindra, Carl Schildkraut, Yu-Hang Chen, Sandy Chang
Microcephalin 1/BRIT1-TRF2 interaction promotes telomere replication and repair, linking telomere dysfunction to primary microcephaly. Nature communications 11 (1) (2020)
Yanke Chen, Ting Jiang, Hongyi Zhang, Xingchun Gou, Cong Han, Jianhui Wang, Ann T Chen, Jun Ma, Jun Liu, Zeming Chen, Xintao Jing, Hong Lei, Zhenzhen Wang, Youmei Bao, Mehdi Baqri, Yong Zhu, Ranjit S Bindra, James E Hansen, Jun Dou, Chen Huang, Jiangbing Zhou
LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. Nature cell biology 22 (10) (2020)
Xun Bao, Jianmei Wu, Brian Shuch, Patricia LoRusso, Ranjit S Bindra, Jing Li
Quantitative Profiling of Oncometabolites in Frozen and Formalin-Fixed Paraffin-Embedded Tissue Specimens by Liquid Chromatography Coupled with Tandem Mass Spectrometry. Scientific reports 9 (1) (2019)
Nathan R Fons, Ranjini K Sundaram, Gregory A Breuer, Sen Peng, Ryan L McLean, Aravind N Kalathil, Mark S Schmidt, Diana M Carvalho, Alan Mackay, Chris Jones, Angel Montero Carcaboso, Javad Nazarian, Michael E Berens, Charles Brenner, Ranjit S Bindra
PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma. Nature communications 10 (1) (2019)
Parker L Sulkowski, Ranjini K Sundaram, Sebastian Oeck, Christopher D Corso, Yanfeng Liu, Seth I Noorbakhsh, Monica Niger, Marta Boeke, Daiki Ueno, Aravind Nambiar Kalathil, Xun Bao, Jing Li, Brian Shuch, Ranjit S Bindra, Peter M Glazer
Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair. Nature genetics 50 (8) (2018)